Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 05-2013 | 03-2013 | 02-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,396 | -2,156 | -50 | -1,015 | -8 |
| Depreciation Amortization | 111 | 54 | 3 | 23 | N/A |
| Accounts payable and accrued liabilities | 102 | 25 | 2 | 71 | N/A |
| Other Working Capital | -65 | -3 | 2 | 29 | N/A |
| Other Operating Activity | -50 | 24 | -2 | -55 | 0 |
| Operating Cash Flow | $-3,298 | $-2,056 | $-46 | $-947 | $-7 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -257 | -247 | -50 | -230 | N/A |
| Investing Cash Flow | $-257 | $-247 | $-50 | $-230 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2 | N/A | 2 |
| Debt Issued | 1,000 | 500 | N/A | 500 | N/A |
| Common Stock Issued | 6 | 6 | 92 | N/A | 92 |
| Other Financing Activity | 3 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,008 | $506 | $94 | $500 | $94 |
| Beginning Cash Position | 5,032 | 5,032 | 5 | 5,032 | 5 |
| End Cash Position | 2,486 | 3,235 | 3 | 4,355 | 91 |
| Net Cash Flow | $-2,547 | $-1,797 | $-2 | $-677 | $86 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,298 | -2,056 | -46 | -947 | -7 |
| Capital Expenditure | -257 | -247 | -50 | -230 | N/A |
| Free Cash Flow | -3,555 | -2,303 | -96 | -1,177 | -7 |